The main purpose of this Manual is to provide useful guidelines for the selection of pathology tests and to facilitate interpretation of results.
Contains a comprehensive listing of all genes from the Human Gene Nomenclature Committee (HGNC) database alongside laboratories and tests available in the country.
A manual for the process of macroscopic dissection in Anatomical Pathology laboratories.
Donate online now using the button below. RCPA Foundation thanks you for your generous support. All funds raised will be allocated to the RCPA Foundation Pathology Education Outreach Fellowship.
Events and Sponsorship Manager
Ph: +61 2 8356 5806
Fax: +61 2 8356 5828
Events and Grants Coordinator
Ph: +61 2 8356 5852
Fax: +61 2 8356 5828
Keywords: LA, Lupus inhibitor, LAC
4.5 mL blood added to 0.5 mL citrate.
Conventional coagulation specimen may not be suitable as the sample has to be first depleted of platelets before testing.
Indicate this test clearly on the request form so that it can be processed differently by the laboratory (that is, either double spun or filtered prior to freezing).
A number of techniques are in use including Kaolin clotting time, PT using dilute thromboplastin, dilute Russell viper venom time, platelet neutralisation procedure.
Investigation of prolonged APTT not corrected by a 1:1 mix with plasma; SLE; unexplained recurrent fetal loss, vascular thrombosis, young adults (<50 years) with ischaemic stroke.
Testing is also recommended for patients with unprovoked proximal DVT.
Lupus inhibitors reported in 5-10% of patients with SLE, but are more commonly seen without clinical or serological evidence of SLE. They are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.
Increased risk of bleeding is not generally associated with the presence of a lupus anticoagulant, however may be related to associated thrombocytopenia or specific coagulation factor inhibitor, or in rare cases of lupus inhibitors associated with prothrombin consumption.
See also Cardiolipin Ab and Phospholipid antibody syndrome.
Keeling D et al. Guidelines for the investigation and management of antiphospholipid syndrome. BJH. 2012; 157: 47-58.
Exner T et al. Br J Haematol .1987; 17: 143-151.
Triplett DA et al. Br J Haematol. 1989; 73: 139-142.
Harris EN. Br J Haematol. 1990; 74: 1-10.
Galli M et al. Blood. 2003; 101: 1827-1832.
Page last updated:
The RCPA is the leading organisation representing Pathologists and Senior Scientists in Australasia.
Its mission is to train and support pathologists and senior scientists and to improve the use of pathology testing to achieve better healthcare.
Copyright © 2020 RCPA. All rights reserved.